Intercept to Present at Upcoming Investor Conferences
20 February 2021 - 12:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that Jerry Durso, President and Chief Executive
Officer, and Sandip Kapadia, Chief Financial Officer of Intercept,
will present at the SVB Leerink 10th Annual Global Healthcare
Conference on Friday, February 26, 2021 at 1:00 p.m. ET, and at the
Cowen 41st Annual Healthcare Conference on Tuesday, March 2, 2021
at 10:30 a.m. ET.
A live webcast of the events will be available on the investor
page of Intercept’s website at http://ir.interceptpharma.com. An
audio archive of the webcast will also be available on Intercept’s
website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept has
operations in the United States, Europe and Canada. For more
information, please visit www.interceptpharma.com or
connect with the company
on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2024 to May 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From May 2023 to May 2024